R. A. Michael

A joint clinical research center in Thailand: role in HIV vaccine development.

S. Nitayaphan, J. Excler, Arthur E. Brown, 2003, The Southeast Asian journal of tropical medicine and public health.

Evaluation of behavioral and social issues among Thai HIV vaccine trial volunteers.

S. Nitayaphan, J. McNeil, C. Khamboonruang, 1999, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

HIV Risk Behavior Patterns Among Young Thai Men

S. Nitayaphan, R. Jenkins, C. Mason, 1999, AIDS and Behavior.

Motivation, recruitment, and screening of volunteers for a phase I/II HIV preventive vaccine trial in Thailand.

S. Nitayaphan, J. Chiu, C. Khamboonruang, 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Correlates of HIV-1 seropositivity among young men in Thailand.

D. Burke, J. Carr, F. McCutchan, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Declining prevalence of HIV‐1 infection in young Thai men

J. Carr, S. Nitayaphan, J. McNeil, 1995, AIDS.

Feasibility of a preventive HIV-1 vaccine cohort among persons attending sexually transmitted disease clinics in Thailand.

A. Brown, L. Markowitz, N. Sirisopana, 1999, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Nationwide surveillance of HIV-1 prevalence and subtype in young Thai men.

S. Nitayaphan, C. Mason, L. Markowitz, 1998, Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology.

Predictors of HIV‐1 Disease Progression in Early‐ and Late‐Stage Patients: The U.S. Army Natural History Cohort

Naomi E. Aronson, Donald S. Burke, R. H. Gates, 1992, Journal of acquired immune deficiency syndromes.

A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative Thais.

J. Mascola, D. Birx, S. Nitayaphan, 2000 .

A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative thais.AFRIMS-RIHES Vaccine Evaluation Group. Armed Forces Research Institute of Medical Sciences and the Research Institute for Health Sciences.

J. Mascola, D. Birx, S. Nitayaphan, 2000, Vaccine.

Dual infection with human immunodeficiency virus type 1 of distinct envelope subtypes in humans.

J. Mascola, J. Carr, E. Sanders-Buell, 1995, The Journal of infectious diseases.